Federal Supply Schedule 36F79723D0104
Award Date
4/15/23
Last Date to Order
4/14/28
Federal Agency
Veterans Integrated Service Network 12
Awardee
Heritage Pharmaceuticals Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products, awarded by the Department of Veterans Affairs (VA) to Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc. The contract has a ceiling value of $25,000 and a period of performance through April 2023. Additionally, Heritage Pharmaceuticals holds a separate $1.5 million FSS Schedule 65 IB contract with the VA that runs...
This Federal Supply Schedule contract was awarded by the U.S. Department of Veterans Affairs (VA) to Heron Therapeutics, Inc. for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract was awarded on October 15, 2017 and has a ceiling value of $30,144,280. The period of performance extends until September 14, 2025. This is a multiple award contract under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule, and there was no set-aside used. The...
This is a multiple award Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs Veterans Health Administration (VA VHA), awarded to Mylan Specialty LP as the prime contractor. The contract, with a potential ceiling value of $514,849,130, is for the procurement of pharmaceuticals, drugs, hematology products, and related medical supplies to support the healthcare needs of U.S. veterans.
The contract falls under FSS Schedule 65 IB, "Drugs, Pharmaceuticals, &...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Patriot Pharmaceuticals LLC, a for-profit manufacturer of goods. The contract, valued at $23,177,724.00, is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for the Veterans Integrated Service Network 12. The contract has a period of performance from January 1, 2023 to December 31, 2027. As a Federal Supply Schedule contract, it is a multiple award vehicle...
The provided information details a Federal Supply Schedule (FSS) contract award to Aveo Pharmaceuticals, Inc. by the U.S. Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The $45,580,967.00 ceiling value contract has an ultimate completion date of October 14, 2026.
The contract aims to procure pharmaceutical and hematology-related products to support the VA's healthcare operations. As an FSS contract, it allows for the placement of task...
The U.S. Department of Veterans Affairs (VA) awarded a Federal Supply Schedule (FSS) contract IDV to Phathom Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical and hematology-related products. The $250,000 multiple-award contract (36F79724D0154) enables the VA's Veterans Integrated Service Network 12 to procure drugs, pharmaceuticals, and hematology products under the Federal Supply Classification code 65 I B. The contract has a period of performance from July 1, 2024, to June...
The Department of Veterans Affairs awarded a Federal Supply Schedule contract to Vyera Pharmaceuticals, LLC to procure drugs, pharmaceuticals, and related hematology products. The potential value of this multiple award schedule is $3.5 million with an ordering period through September 2029.
Additionally, the National Acquisition Center established a single award Blanket Purchase Agreement with Vyera Pharmaceuticals on behalf of the Veterans Health Administration. Valued at $450,000, this BPA...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs (VA) to Agepha Pharma USA LLC, a foreign-owned, self-certified small disadvantaged business and woman-owned small business. The contract, under FSS Schedule 65 IB for Drugs, Pharmaceuticals, & Hematology Related Products, has a ceiling value of $25,000.00 and a period of performance through June 14, 2024.
The purpose of this interim agreement is to provide the VA with access to a variety of...
This federal contract is an Indefinite Delivery Vehicle (IDV) awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The contract is a Federal Supply Schedule (FSS) under Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related Products. The prime contractor is Avvisto Therapeutics LLC, a for-profit limited liability company that manufactures goods.
The contract has a ceiling value of $25,000.00...
This is a Federal Supply Schedule (FSS) contract awarded by the U.S. Department of Veterans Affairs (VA) to Royal Pharmaceuticals LLC, a foreign-owned for-profit organization. The contract, valued at up to $750,000.00, is for the provision of pharmaceutical and hematology-related products under the Pharmaceuticals and Drugs (FSS-61-IB) schedule.
The contract has an ultimate completion date of September 30, 2025 and was awarded on October 1, 2019. It is a multiple-award contract, meaning there...